EGFR and neoplasm: The upregulation of chemokine expression by anti-EGFR mAb 3 promotes the infiltration of leukocytes into tumor spheroids. This unique mechanism of action of anti-EGFR mAb could potentially enhance the anti-tumor effects of the antibody in living organisms.